Improving communication and collaboration in tobacco regulatory science
Official title: Administrative Core
Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-10934554 · Data updated 2026-11-12
This study is all about helping researchers at Penn State and other partner institutions work better together to improve tobacco research, making sure they follow the rules and keep everything ethical, so they can find better ways to understand and regulate tobacco use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State Univ Hershey Med Ctr NIH-funded |
| Lab location | 1 site (Hershey, United States) |
| Project start | September 30, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $360,899 |
| NIH project number | 5U54DA058271-02 |
| Project ID | NIH-10934554 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals involved in tobacco regulatory science, public health officials, and researchers in related fields.
✕Less likely to help
Patients who are not involved in tobacco research or regulatory practices may not receive direct benefits from this initiative.
What this research studies
This research focuses on enhancing communication and collaboration among investigators at Penn State and affiliated institutions, including the University of Texas MD Anderson Cancer Center. It aims to establish governance procedures and prioritize interactions among researchers, regulatory bodies like the FDA and NIH, and external advisory boards. By overseeing ethical and legal responsibilities, the Administrative Core will facilitate scientific studies and ensure adherence to regulatory standards in tobacco research. This initiative is designed to foster a collaborative environment that supports the advancement of tobacco regulatory science.
Why it matters
Potential benefit: If successful, this research could lead to improved regulatory practices and policies in tobacco control, ultimately benefiting public health.
How similar studies have gone: While this approach emphasizes collaboration and governance in tobacco regulatory science, similar initiatives have shown promise in enhancing research outcomes in other health-related fields.
Where this research is happening
-
Pennsylvania State Univ Hershey Med Ctr
Hershey, United States Active
Researchers
- Principal investigator: Muscat, Joshua E — Pennsylvania State Univ Hershey Med Ctr
- Study coordinator: Muscat, Joshua E
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Understanding the STIM/Orai Calcium Signaling Pathway in Cancer
Researchers are studying how STIM and Orai proteins control calcium signals inside cells and how this affects cancer-related growth and remodeling, with hopes to find ways to influence these signals for better treatments.
-
Understanding how some Amish communities maintain high birth rates in modern times
A project will build a large, time-sensitive dataset to understand why Amish families keep having many children, even as broader society has much lower birth rates.
-
Scoliosis and neurosurgical factors in myelomeningocele: a clinic registry study
This project uses registry data from Penn State’s Spina Bifida Clinic to understand how brain and spine-related issues influence when and why scoliosis surgery is needed in people with myelomeningocele.
-
Understanding how damaged stomach cells revert to a repair state to prevent cancer
Researchers are studying how certain stomach cells re-enter the cell cycle to aid tissue repair, and how this process might lead to metaplasia or cancer if it goes wrong.
-
Aging, cell aging, and how MCPyV causes Merkel cell carcinoma
Aging and aging-related changes in skin cells may help a common virus (MCPyV) persist and potentially lead to a rare skin cancer in people with weaker immune systems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.